Literature DB >> 6213275

Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion".

J S Fong, B S Kaplan.   

Abstract

Thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure are the hallmarks of hemolytic-uremic syndrome (HUS). This report presents the results on platelet studies from 10 consecutive HUS patients in childhood. During their acute illness, they all displayed a characteristic pattern of impaired platelet function: no aggregating responses to epinephrine, some to ADP, and moderate to collagen. In addition, platelet contents of beta-thromboglobulin (beta TG) were markedly reduced. As these patients improved clinically, their platelet-aggregating responses also normalized despite their uremic state. Incubation of platelets with uremic plasma or guanidino-succinic acid, a uremic toxin, had minor effects on platelet-aggregating activity. Since low levels of platelet beta TG suggest that these platelets were in an exhausted state, in vitro experiments were performed to exhaust normal platelets by incubation at 37 degrees C. A proportional impairment of platelet-aggregating responses and decreasing levels of platelet beta TG were noted. Furthermore, the pattern of impairment was similar to that found in the platelet-aggregating activities of HUS patients. Thus, "exhaustion," in addition to azotemia and thrombocytopenia, are factors that contribute to the functional impairment of platelets in these patients. Further studies to reveal mechanisms that lead to platelet exhaustion in HUS are of fundamental importance in the understanding of this illness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213275

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Hemostatic studies in patients with infective endocarditis: a report on nine consecutive cases with evidence of coagulopathy.

Authors:  T H Taha; S Durrant; J Crick; S Bowcock; A Bradshaw; C M Oakley
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

Review 2.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 3.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

Review 5.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

6.  Impaired neutrophils in children with the typical form of hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; Sonia A Gómez; Carolina J Rubel; Leticia V Bentancor; Paula Barrionuevo; Marta Alduncín; Irene Grimoldi; Ramón Exeni; Martín A Isturiz; Marina S Palermo
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

7.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome.

Authors:  S A Gomez; M J Abrey-Recalde; C A Panek; N F Ferrarotti; M G Repetto; M P Mejías; G C Fernández; S Vanzulli; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 9.  Alterations in platelet behavior after major trauma: adaptive or maladaptive?

Authors:  Paul Vulliamy; Lucy Z Kornblith; Matthew E Kutcher; Mitchell J Cohen; Karim Brohi; Matthew D Neal
Journal:  Platelets       Date:  2020-01-27       Impact factor: 3.862

Review 10.  Microvesicle Involvement in Shiga Toxin-Associated Infection.

Authors:  Annie Villysson; Ashmita Tontanahal; Diana Karpman
Journal:  Toxins (Basel)       Date:  2017-11-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.